Ken Griffin
SPRB

Ken Griffin’s Spruce Biosciences SPRB Stock Holding History

Ken Griffin’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.57M Hold
69,999
– – ﹤0.01% 4491
2025
Q4 		$6.1M Buy
+69,999
New +$7.5M ﹤0.01% 3973
2024
Q4 		– Sell
-1,027
Closed -$36.6K – 15612
2024
Q3 		$36.6K Sell
1,027
-103
-9% -$3.77K ﹤0.01% 12245
2024
Q2 		$43.9K Sell
1,130
-42
-4% -$2.25K ﹤0.01% 11909
2024
Q1 		$69.1K Sell
1,172
-271
-19% -$68.9K ﹤0.01% 11830
2023
Q4 		$317K Buy
1,443
+443
+44% +$51.2K ﹤0.01% 9053
2023
Q3 		$170K Buy
1,000
+50
+5% +$8.43K ﹤0.01% 10165
2023
Q2 		$153K Sell
950
-21,698
-96% -$3.63M ﹤0.01% 10307
2023
Q1 		$3.75M Sell
22,648
-651
-3% -$121K ﹤0.01% 4283
2022
Q4 		$1.92M Buy
23,299
+238
+1% +$19.9K ﹤0.01% 5558
2022
Q3 		$2.37M Buy
23,061
+68
+0.3% +$9.5K ﹤0.01% 5267
2022
Q2 		$3M Buy
22,993
+35
+0.2% +$4.48K ﹤0.01% 4755
2022
Q1 		$3.46M Sell
22,958
-70
-0.3% -$13K ﹤0.01% 4890
2021
Q4 		$7.7M Buy
23,028
+347
+2% +$103K ﹤0.01% 3527
2021
Q3 		$10.2M Sell
22,681
-26
-0.1% -$16.3K ﹤0.01% 3037
2021
Q2 		$19.1M Buy
22,707
+3
+0% +$3.2K ﹤0.01% 2147
2021
Q1 		$28.3M Buy
22,704
+14
+0.1% +$21.5K 0.01% 1580
2020
Q4 		$41.4M Buy
+22,690
New +$37.6M 0.01% 1104

Other funds holding SPRB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Ken Griffin's SPRB Position: Q1 2026 in Review

Ken Griffin held its Spruce Biosciences (SPRB) position steady in Q1 2026 at 69,999 shares worth $4.57M. The position accounts for ﹤0.01% of the portfolio, ranked #4491.

Ken Griffin first reported a position in SPRB in Q4 2020 and has held it in 18 quarters since. The position peaked at $41.4M in Q4 2020. 32 funds tracked by Wall St. Rank hold SPRB as of Q1 2026.

  • Ken Griffin held 69,999 shares of Spruce Biosciences worth $4.57M as of Q1 2026.
  • Ken Griffin left its Spruce Biosciences share count unchanged in Q1 2026.
  • Spruce Biosciences made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #4491 holding.
  • Ken Griffin first reported a position in Spruce Biosciences in Q4 2020 and has held it in 18 quarters since.
  • Ken Griffin's Spruce Biosciences position peaked at $41.4M in Q4 2020.
  • 32 funds tracked by Wall St. Rank held Spruce Biosciences as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.